Moringa Acquisition (Moringa Acquisition) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Moringa Acquisition Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Moringa Acquisition is: No Data: Cannot be evaluated.

Competitive Comparison of Moringa Acquisition's Risk Assessment

For the Shell Companies subindustry, Moringa Acquisition's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moringa Acquisition's Risk Assessment Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Moringa Acquisition's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Moringa Acquisition's Risk Assessment falls into.

Moringa Acquisition (NAS:MACAU) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Moringa Acquisition Risk Assessment Related Terms

Thank you for viewing the detailed overview of Moringa Acquisition's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Moringa Acquisition (Moringa Acquisition) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Moringa Acquisition Corp (NAS:MACAU) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

MACA:USA

Address

250 Park Avenue, 7th Floor, New York, NY, USA, 10177

Website

https://www.moringaac.com

Moringa Acquisition Corp is a blank check company.

Executives

Hudson Bay Capital Management Lp	10 percent owner	28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Sander Gerber	10 percent owner	C/O HUDSON BAY CAPITAL MANAGEMENT, L.P., 28 HAVEMEYER PLACE, 2ND FLOOR, GREENWICH CT 06830
Ruth Alon	director	1/3 HIGH-TECH VILLAGE, GIVAT RAM, P.O. BOX 39264, JERUSALEM L3 9139102
Eric Brachfeld	director	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Michael Basch	director	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Gil Maman	officer: Chief Financial Officer	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Ilan Levin	director, 10 percent owner, officer: Chairman and CEO	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Moringa Sponsor Us L.p.	10 percent owner	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Moringa Sponsor, Lp	10 percent owner	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 11040
Dan Yalon	officer: Advisor	C/O MORINGA ACQUISITION CORP, 250 PARK AVENUE, 7TH FLOOR, NEW YORK NY 10177